Recursion therapeutics stock
WebApr 5, 2024 · The latest price target for Recursion Pharmaceuticals ( NASDAQ: RXRX) was reported by Needham on Thursday, March 16, 2024. The analyst firm set a price target for 17.00 expecting RXRX to rise to ... WebApr 12, 2024 · Recursion Pharmaceuticals (NASDAQ:RXRX) has filed to raise $306 million in an IPO of its Class A common stock, according to an S-1 registration statement. The firm is developing treatments for ...
Recursion therapeutics stock
Did you know?
WebMar 31, 2024 · RECURSION PHARMACEUTICALS, INC. : Company profile, business summary, shareholders, managers, financial ratings, industry, sector and market information Nasdaq: RXRX Nasdaq RECURSION PHARMACEUTICALS, INC. WebRecursion Pharmaceuticals, Inc. (RXRX) Stock Price, News, Quote & History - Yahoo Finance Recursion Pharmaceuticals, Inc. (RXRX) NasdaqGS - NasdaqGS Real Time Price. Currency in USD Follow 2W... Find the latest Recursion Pharmaceuticals, Inc. (RXRX) stock discussion in Yahoo … As of 02:57PM EDT. Market open. Salt Lake City, April 03, 2024 (GLOBE NEWSWIRE) - … See the company profile for Recursion Pharmaceuticals, Inc. (RXRX) including … See Recursion Pharmaceuticals, Inc. (RXRX) stock analyst estimates, including … Find out all the key statistics for Recursion Pharmaceuticals, Inc. (RXRX), including … Get the detailed quarterly/annual income statement for Recursion … View the basic RXRX option chain and compare options of Recursion … See Recursion Pharmaceuticals, Inc. (RXRX) Environment, Social and Governance … Find the latest Recursion Pharmaceuticals, Inc. (RXRX) stock quote, history, news … Get the latest Recursion Pharmaceuticals, Inc. (RXRX) stock news and headlines to …
WebApr 11, 2024 · According to analysts, Recursion Pharmaceuticals's stock has a predicted upside of 36.20% based on their 12-month price targets. What analysts cover Recursion … Web1. the cause of the disease is well-defined. 2. there is high unmet need, there are no approved therapies, or there are significant shortcomings with existing treatment paradigms. Expanded Access Policy Clinical Trial Transparency.
WebApr 11, 2024 · The 15 analysts offering price forecasts for Recursion Pharmaceuticals, have a median target of 19.93, with a high estimate of 37.00 and a low estimate of 7.00. The median estimate represents a... WebRecursion Pharmaceuticals Inc Follow Share $7.43 After Hours: $7.43 (0.00%) 0.00 Closed: Mar 21, 4:01:10 PM GMT-4 · USD · NASDAQ · Disclaimer search Compare to Pfizer Inc. $40.66 PFE0.37% NVIDIA...
WebApr 11, 2024 · Recursion Pharmaceuticals, stock has received a consensus rating of hold. The average rating score is and is based on 5 buy ratings, 10 hold ratings, and 0 sell ratings. m\u0026m internationalWebRecursion Pharmaceuticals - Crunchbase Company Profile & Funding Oops! There was a problem! There was an unexpected issue while trying to process your request. Please … how to make story on instagram webWebApr 10, 2024 · SVB Securities analyst Mani Foroohar reiterated a Hold rating on Recursion Pharmaceuticals (RXRX - Research Report) on February 27 and set a price target of $9.00. … m \u0026 m insurance new castle paWebApr 10, 2024 · Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral ... m \u0026 m inflatables ironton ohWebWe would like to show you a description here but the site won’t allow us. m \u0026 m insurance hemphillWebMar 16, 2024 · In a report released today, Gil Blum from Needham initiated coverage with a Buy rating on Recursion Pharmaceuticals and a price target of $17.00. The company’s … m \u0026 m industries morgan cityWebFeb 17, 2024 · Recursion Pharmaceuticals completed its IPO in 2024, raising >$500m. The company is promising to revolutionize drug discovery with AI - although the evidence for … m\\u0026 m industries chattanooga